Tingyu Liu
State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Radiation-induced nuclear translocation of NPRL2 hijacks E3 ubiquitin ligases to enhance DNA repair via the AMPK/WDR24 axis, contributing to CRC radioresistance.
Journal: Acta pharmaceutica Sinica. B
Published: April 10, 2025
Nilotinib in combination with sunitinib renders MCL-1 for degradation and activates autophagy that overcomes sunitinib resistance in renal cell carcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: February 14, 2024
Caged Luciferase Inhibitor-Based Bioluminescence Switching Strategy Enables Efficient Detection of Serum APN Activity and the Identification of Its Roles in Metastasis of Non-Small Cell Lung Cancer.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: March 01, 2023
Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy.
Journal: Acta pharmaceutica Sinica. B
Published: November 27, 2022
Prognostic significance and immune correlates of FADD in penile squamous cell carcinoma.
Journal: Virchows Archiv : an international journal of pathology
Published: September 19, 2022
First-line programmed death receptor-1 (PD-1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum-based chemotherapy, for stage IV penile cancer.
Journal: BJU international
Published: June 15, 2022
Mitochondrial creatine kinase 1 regulates the cell cycle in non-small cell lung cancer via activation of cyclin-dependent kinase 4.
Journal: Respiratory research
Published: May 02, 2022
Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradation.
Journal: Molecular therapy oncolytics
Published: February 09, 2022
Identification of 2-Benzylidene-tetralone Derivatives as Highly Potent and Reversible Firefly Luciferase Inhibitors.
Journal: ACS medicinal chemistry letters
Published: December 01, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026